Document is current

Any future updates will be listed below

Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-020-02257-1

Published Online: 2020-07-02

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark